LifePlan Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.64M Buy
21,005
+851
+4% +$68.7K 1.15% 27
2026
Q1
$1.75M Sell
20,154
-2,772
-12% -$266K 1.29% 21
2025
Q4
$2.2M Sell
22,926
-301
-1% -$29.2K 1.69% 15
2025
Q3
$2.21M Buy
23,227
+272
+1% +$25K 1.75% 14
2025
Q2
$2M Buy
22,955
+176
+0.8% +$14.9K 1.66% 16
2025
Q1
$2.05M Buy
22,779
+452
+2% +$40.4K 1.79% 16
2024
Q4
$1.78M Buy
22,327
+822
+4% +$71.2K 1.58% 18
2024
Q3
$1.94M Buy
21,505
+1,329
+7% +$112K 1.66% 17
2024
Q2
$1.59M Buy
20,176
+791
+4% +$64.8K 1.46% 20
2024
Q1
$1.69M Buy
19,385
+1,212
+7% +$103K 1.55% 14
2023
Q4
$1.5M Buy
+18,173
New +$1.39M 1.5% 17

Other funds holding MDT

LifePlan Financial's MDT Position: Q2 2026 in Review

LifePlan Financial increased its Medtronic (MDT) stake by 4.2% in Q2 2026, buying an estimated $68.7K and bringing the position to 21,005 shares worth $1.64M. The position accounts for 1.15% of the portfolio, ranked #27.

LifePlan Financial first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.21M in Q3 2025. 901 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • LifePlan Financial held 21,005 shares of Medtronic worth $1.64M as of Q2 2026.
  • LifePlan Financial bought 851 Medtronic shares in Q2 2026, an estimated $68.7K.
  • Medtronic made up 1.15% of LifePlan Financial's portfolio in Q2 2026, its #27 holding.
  • LifePlan Financial first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • LifePlan Financial's Medtronic position peaked at $2.21M in Q3 2025.
  • 901 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on LifePlan Financial's 13F filing for Q2 2026, filed 21 Jul 2026.